Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Severe aplastic anemia].

W Hinterberger1

  • 1I. Medizinischen Universitätsklinik Wien.

Wiener Medizinische Wochenschrift (1946)
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Severe aplastic anemia is a rare, often fatal disorder. Early bone marrow transplant or immunosuppression can cure or rescue patients, but timely intervention is crucial before complications arise.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improved outcome in patients with chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation over the past 25 years: a single-center experience.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2010
Same author

Spontaneous changes in tumour cell dissemination to bone marrow in colorectal cancer.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2009
Same author

Caspase-cleaved cytokeratin 18 fragment (M30) as marker of postoperative residual tumor load in colon cancer patients.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2009
Same author

Capsule endoscopy with retention of the capsule in a duodenal diverticulum.

Endoscopy·2008
Same author

Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia.

Bone marrow transplantation·2006
Same author

Diagnostic challenges of hepatitis C virus infections.

Drugs of today (Barcelona, Spain : 1998)·2004

Area of Science:

  • Hematology
  • Internal Medicine
  • Transplantation Medicine

Background:

  • Severe aplastic anemia (SAA) is a rare and frequently fatal hematologic disorder.
  • The etiology of SAA in individual patients is typically unidentifiable through standard laboratory tests.
  • SAA necessitates prompt therapeutic intervention to prevent life-threatening complications like infection and bleeding.

Purpose of the Study:

  • To outline the critical importance of early therapeutic interventions for severe aplastic anemia.
  • To discuss the primary treatment modalities for SAA, including bone marrow transplantation and immunosuppressive therapy.
  • To highlight the factors influencing treatment decisions, such as patient age and donor availability.

Main Methods:

  • Review of established treatment protocols for severe aplastic anemia.

Related Experiment Videos

  • Analysis of patient age and HLA-identical bone marrow donor availability as key decision-making factors.
  • Emphasis on the timing of interventions in relation to disease progression and complications.

    • Main Results:

    • Early bone marrow transplantation can achieve up to an 80% cure rate in eligible patients.
    • Intensive immunosuppressive regimens can effectively rescue many patients with SAA.
    • Delayed treatment increases the risk of severe complications, reducing treatment efficacy.

    Conclusions:

    • Timely administration of bone marrow transplantation or immunosuppression is essential for managing severe aplastic anemia.
    • Treatment decisions for SAA are individualized based on patient age and HLA-identical donor availability.
    • Prompt therapeutic application significantly improves outcomes and survival rates in severe aplastic anemia patients.